基本信息
views: 15

Bio
Dr. Jian Chen has been a Principal Investigator at the Peking University Shenzhen Hospital since 2020, and his research interest is epigenetics and related drug development in cancer and immune diseases. Currently, Dr. Chen is in charge of the National Natural Science Foundation of China and other funds totaling 2.8 million RMB. In the last 5 years, Dr. Chen has published 28 peer-reviewed research articles in prestigious journals (total impact factor > 190) as the first author or corresponding author and holds 8 authorized invention patents. Dr. Chen also sits on the editorial board of several journals and served as a reviewer of many famous journals.
Research Interests
Papers共 55 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Bioorganic chemistry (2025): 108538-108538
Frontiers in immunology (2025): 1613013-1613013
Xian Lin,Jian Chen
Frontiers in pharmacology (2025): 1578971-1578971
Gabriele Casagrande Raffi,Jian Chen, Xuezhao Feng, Zhen Chen,Cor Lieftink,Shuang Deng, Jinzhe Mo, Chuting Zeng, Marit Steur,Jing Wang,Onno B. Bleijerveld,Liesbeth Hoekman, Nicole van der Wel, Feng Wang,Roderick Beijersbergen,Jian Zheng,Rene Bernards,Liqin Wang
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAno. 52 (2024)
BIOMEDICINE & PHARMACOTHERAPY (2024)
Journal of Functional Foods (2024): 106394-106394
Dong Chen, Guangxin Li,Lianxiang Luo,Tengyu Lin,Xinyu Chu, Kangdi Liu,Tianli Lai, Yinglin Liao, Xian Lin,Jian Chen
PHYTOMEDICINE (2024)
INTERNATIONAL IMMUNOPHARMACOLOGY (2024)
Load More
Author Statistics
#Papers: 55
#Citation: 895
H-Index: 15
G-Index: 29
Sociability: 5
Diversity: 3
Activity: 24
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn